Published in AIDS on November 10, 2000
Systematic review and meta-analysis of evidence for increasing numbers of drugs in antiretroviral combination therapy. BMJ (2002) 1.21
Quality of life among individuals with HIV starting antiretroviral therapy in diverse resource-limited areas of the world. AIDS Behav (2012) 1.13
Self-reported health-related quality of life in persons with HIV infection: results from a multi-site interview project. Health Qual Life Outcomes (2003) 1.06
Higher quality of life and lower depression for people on ART in Uganda as compared to a community control group. PLoS One (2014) 0.83
Quality of life in patients treated with first-line antiretroviral therapy containing nevirapine or efavirenz in Uganda: a prospective non-randomized study. BMC Health Serv Res (2015) 0.75
Why don't physicians follow clinical practice guidelines? A framework for improvement. JAMA (1999) 40.60
The effectiveness of right heart catheterization in the initial care of critically ill patients. SUPPORT Investigators. JAMA (1996) 17.62
Antiretroviral drug resistance testing in adult HIV-1 infection: recommendations of an International AIDS Society-USA Panel. JAMA (2000) 7.81
Medical error: the second victim. The doctor who makes the mistake needs help too. BMJ (2000) 7.67
Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA Study Group. Lancet (1998) 7.53
Perceptions by family members of the dying experience of older and seriously ill patients. SUPPORT Investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments. Ann Intern Med (1997) 6.55
Antiretroviral therapy in adults: updated recommendations of the International AIDS Society-USA Panel. JAMA (2000) 6.49
Antiretroviral therapy for HIV infection in 1997. Updated recommendations of the International AIDS Society-USA panel. JAMA (1997) 6.35
Antiretroviral therapy for HIV infection in 1996. Recommendations of an international panel. International AIDS Society-USA. JAMA (1996) 5.29
Antiretroviral therapy for HIV infection in 1998: updated recommendations of the International AIDS Society-USA Panel. JAMA (1998) 4.61
Antiretroviral drug resistance testing in adults with HIV infection: implications for clinical management. International AIDS Society--USA Panel. JAMA (1998) 4.42
Self-reported symptoms and medication side effects influence adherence to highly active antiretroviral therapy in persons with HIV infection. J Acquir Immune Defic Syndr (2001) 3.83
Health values of hospitalized patients 80 years or older. HELP Investigators. Hospitalized Elderly Longitudinal Project. JAMA (1998) 3.47
Development and validation of a self-completed HIV symptom index. J Clin Epidemiol (2001) 3.28
Quality of life in HIV-infected individuals receiving antiretroviral therapy is related to adherence. AIDS Care (2005) 3.06
Relative increase of T cells expressing the gamma/delta rather than the alpha/beta receptor in ataxia-telangiectasia. N Engl J Med (1990) 2.69
Comparison of long-term prognosis of patients with AIDS treated and not treated with zidovudine. AIDS in Europe Study Group. JAMA (1994) 2.56
Thalidomide for the treatment of oral aphthous ulcers in patients with human immunodeficiency virus infection. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group. N Engl J Med (1997) 2.55
The complete nucleotide sequence of the gene coding for diphtheria toxin in the corynephage omega (tox+) genome. Nucleic Acids Res (1983) 2.51
Older age, aggressiveness of care, and survival for seriously ill, hospitalized adults. SUPPORT Investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments. Ann Intern Med (1999) 2.34
In vivo resistance to a human immunodeficiency virus type 1 proteinase inhibitor: mutations, kinetics, and frequencies. J Infect Dis (1996) 2.34
Health-related quality of life in patients with human immunodeficiency virus infection in the United States: results from the HIV Cost and Services Utilization Study. Am J Med (2000) 2.31
Factors associated with a reduced CD4 lymphocyte count response to HAART despite full viral suppression in the EuroSIDA study. HIV Med (2003) 2.30
Reliability and validity of physical and mental health summary scores from the Medical Outcomes Study HIV Health Survey. Med Care (1998) 2.21
Health values of the seriously ill. SUPPORT investigators. Ann Intern Med (1995) 2.14
Dying with lung cancer or chronic obstructive pulmonary disease: insights from SUPPORT. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments. J Am Geriatr Soc (2000) 2.09
A controlled trial of early adjunctive treatment with corticosteroids for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. California Collaborative Treatment Group. N Engl J Med (1990) 2.04
High exposure to nevirapine in plasma is associated with an improved virological response in HIV-1-infected individuals. AIDS (2001) 2.03
Survival of AIDS patients according to type of AIDS-defining event. The AIDS in Europe Study Group. Int J Epidemiol (1997) 1.97
Adherence to antiretroviral and pneumocystis prophylaxis in HIV disease. J Acquir Immune Defic Syndr Hum Retrovirol (1998) 1.89
Quality of life among women living with HIV: the importance violence, social support, and self care behaviors. Soc Sci Med (2001) 1.89
Nocturnal asthma in children affects school attendance, school performance, and parents' work attendance. Arch Pediatr Adolesc Med (2000) 1.81
Suppression of plasma viral load below 20 copies/ml is required to achieve a long-term response to therapy. AIDS (1998) 1.81
Sensitivity, specificity, reliability, and clinical validity of provider-reported symptoms: a comparison with self-reported symptoms. Outcomes Committee of the AIDS Clinical Trials Group. J Acquir Immune Defic Syndr (1999) 1.74
Measuring quality of life among HIV-infected women using a culturally adapted questionnaire in Rakai district, Uganda. AIDS Care (2004) 1.74
The amino-acid sequence of two non-toxic mutants of diphtheria toxin: CRM45 and CRM197. Nucleic Acids Res (1984) 1.60
Race and sex differences in consistency of care with national asthma guidelines in managed care organizations. Arch Intern Med (2001) 1.60
Quality of life assessment comes of age in the era of highly active antiretroviral therapy. AIDS (2000) 1.58
A three-year diagnostic and epidemiological study on viral infantile diarrhoea in Rome. Epidemiol Infect (1988) 1.57
Derivation and properties of a brief health status assessment instrument for use in HIV disease. J Acquir Immune Defic Syndr Hum Retrovirol (1995) 1.55
SPECT during sleepwalking. Lancet (2000) 1.54
The relationship between ritonavir plasma levels and side-effects: implications for therapeutic drug monitoring. AIDS (1999) 1.52
Health status versus quality of life in older patients: does the distinction matter? Am J Med (1999) 1.50
The Quality of Well-being Scale. Applications in AIDS, cystic fibrosis, and arthritis. Med Care (1989) 1.49
Public reporting of healthcare-associated infection data in Europe. What are the views of infection prevention opinion leaders? J Hosp Infect (2012) 1.49
Comparison of quality of care by specialist and generalist physicians as usual source of asthma care for children. Pediatrics (2001) 1.47
Searches for Lepton flavor violation in the decays tau{+/-}-->e{+/-}gamma and tau{+/-}-->mu{+/-}gamma. Phys Rev Lett (2010) 1.44
Epidemiology of AIDS dementia complex in Europe. AIDS in Europe Study Group. J Acquir Immune Defic Syndr Hum Retrovirol (1996) 1.43
Family satisfaction with end-of-life care in seriously ill hospitalized adults. J Am Geriatr Soc (2000) 1.42
Clinical and immuno-virologic characterization of the efficacy of stavudine, lamivudine, and indinavir in human immunodeficiency virus infection. J Pediatr (1999) 1.41
Decision-making and outcomes of prolonged ICU stays in seriously ill patients. J Am Geriatr Soc (2000) 1.41
Survival differences in European patients with AIDS, 1979-89. The AIDS in Europe Study Group. BMJ (1994) 1.41
Outcomes and cost-effectiveness of initiating dialysis and continuing aggressive care in seriously ill hospitalized adults. SUPPORT Investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments. Ann Intern Med (1997) 1.39
False positives and false negatives: is the answer relatively simple? Acta Psychiatr Scand (2012) 1.39
Treatment patterns among adult patients with asthma: factors associated with overuse of inhaled beta-agonists and underuse of inhaled corticosteroids. Arch Intern Med (2000) 1.39
A randomized comparison of two instruments for measuring self-reported antiretroviral adherence. AIDS Care (2008) 1.35
Oleander poisoning: treatment with digoxin-specific Fab antibody fragments. Ann Emerg Med (1988) 1.35
Age-related differences in care preferences, treatment decisions, and clinical outcomes of seriously ill hospitalized adults: lessons from SUPPORT. J Am Geriatr Soc (2000) 1.34
Optimizing care for persons with HIV infection. Society of General Internal Medicine AIDS Task Force. Ann Intern Med (1999) 1.34
The early growth response gene EGR-1 behaves as a suppressor gene that is down-regulated independent of ARF/Mdm2 but not p53 alterations in fresh human gliomas. Clin Cancer Res (2001) 1.33
Patient-reported nonadherence to HAART is related to protease inhibitor levels. J Acquir Immune Defic Syndr (2000) 1.31
The relationship of excess body weight and health-related quality of life: evidence from a population study in Taiwan. Int J Obes (Lond) (2006) 1.30
Consistency of care with national guidelines for children with asthma in managed care. J Pediatr (2001) 1.30
Updated European recommendations for the clinical use of HIV drug resistance testing. Antivir Ther (2004) 1.28
Preferences for cardiopulmonary resuscitation: physician-patient agreement and hospital resource use. The SUPPORT Investigators. J Gen Intern Med (1995) 1.26
Prediction of survival for older hospitalized patients: the HELP survival model. Hospitalized Elderly Longitudinal Project. J Am Geriatr Soc (2000) 1.24
Determinants of health-related quality of life in HIV-infected patients. AIDS Care (2003) 1.22
How reliable is peer review of scientific abstracts? Looking back at the 1991 Annual Meeting of the Society of General Internal Medicine. J Gen Intern Med (1993) 1.22
Reliability and validity of the SF-36 in HIV-infected homeless and marginally housed individuals. Qual Life Res (2003) 1.20
Quality of life in asymptomatic- and symptomatic HIV infected patients in a trial of ritonavir/saquinavir therapy. The Prometheus Study Group. AIDS (2000) 1.18
Prevalence and characteristics of multinucleoside-resistant human immunodeficiency virus type 1 among European patients receiving combinations of nucleoside analogues. Antimicrob Agents Chemother (2000) 1.18
Handling hospital errors: is disclosure the best defense? Ann Intern Med (1999) 1.17
Interruption of combination antiretroviral therapy and risk of clinical disease progression to AIDS or death. HIV Med (2007) 1.17
Treatment with protease inhibitors and coinfection with hepatitis C virus are independent predictors of preterm delivery in HIV-infected pregnant women. J Infect Dis (2007) 1.16
Subtracting insult from injury: addressing cultural expectations in the disclosure of medical error. J Med Ethics (2005) 1.16
Patient's view of dialysis care: development of a taxonomy and rating of importance of different aspects of care. CHOICE study. Choices for Healthy Outcomes in Caring for ESRD. Am J Kidney Dis (1997) 1.15
Pharmacokinetics of nelfinavir in HIV-1-infected pregnant and nonpregnant women. Br J Clin Pharmacol (2006) 1.15
Regional differences in use of antiretroviral agents and primary prophylaxis in 3122 European HIV-infected patients. EuroSIDA Study Group. J Acquir Immune Defic Syndr Hum Retrovirol (1997) 1.14
Neurocognitive impairment influences quality of life in HIV-infected patients receiving HAART. Int J STD AIDS (2004) 1.12
Effect of sex, age and transmission category on the progression to AIDS and survival of zidovudine-treated symptomatic patients. AIDS (1995) 1.10
Expression of trKB neurotrophin receptor during T cell development. Role of brain derived neurotrophic factor in immature thymocyte survival. J Immunol (1996) 1.09
Beyond "see one, do one, teach one": toward a different training paradigm. Qual Saf Health Care (2009) 1.08
Open prostatectomy in benign prostatic hyperplasia: 10-year experience in Italy. Eur Urol (1998) 1.08
Development of drug resistance in patients receiving combinations of zidovudine, didanosine and nevirapine. AIDS (2001) 1.07
Early immune reconstitution after potent antiretroviral therapy in HIV-infected children correlates with the increase in thymus volume. AIDS (2000) 1.07
Precise measurement of the e+e- --> pi+pi-(gamma) cross section with the initial state radiation method at BABAR. Phys Rev Lett (2009) 1.07
Use of focus groups to identify concerns about dialysis. Choice Study. Med Decis Making (1999) 1.06
Measurement of |V(cb)| and the form-factor slope in B --> Dl- nu(l) decays in events tagged by a fully reconstructed B meson. Phys Rev Lett (2010) 1.05
Vaginal transmission of HIV-1 in hu-SCID mice: a new model for the evaluation of vaginal microbicides. AIDS (2001) 1.04